Pfizer shares fall as 2024 revenue and profit forecast disappoints

After raking in billions from Covid products, Pfizer has struggled to navigate a world beyond the pandemic and reassure investors about its growth potential.

Previous post Wholesale prices held flat in November, providing another encouraging inflation signal
Next post Washington sports teams Capitals, Wizards to move to new Virginia complex in 2028